The consortium led by ParaMedir awarded with more than €1.8 Million in European Funding by Just Transition Fund (JTF)

Subsidy awarded

The consortium led by ParaMedir awarded with more than €1.8 Million in European Funding by JustTransition Fund (JTF) to advance Healthcare through innovative biomonitoring solutions.

ParaMedir proudly announces the award of approximately €1.8 million in Europeanfunding from the Just Transition Fund (JTF). This funding supports a consortium led by ParaMedir which includes Pieter Oomen Beheer, Health Hub Roden, GitGud Software Development, University Medical Center Groningen (UMCG), Zorggroep Tangenborgh, and Hanze University Groningen in advancing healthcare through innovative biomonitoring solutions by tackling the challenges of diagnosing and monitoring acute and chronic illnesses. Our goal is to enhance biomonitoring for patients with acute and chronic illnesses, such as diabetes, adhering to the"better in, better out" principle.

About the project

Expanding on ParaMedir's UriMoni™ device, which uses microbiosensors and microfluidics to monitor key urine biomarkers, this project aims to extend this technology to various biological fluids like urine, sweat, and saliva. Collaborative efforts will result in significant advances not only in ParaMedir’s core technologies but also in adjacent technologies like bioelectronics, and artificial intelligence, with key objectives focused on developing advanced biosensors, microfluidic solutions, and software algorithms for seamless data analysis by creating prototypes for both hospital and home use, along with a cloud-based application for real-time clinical data access integrated with existing health record systems. These advancements will offer real-time health insights, personalized interventions, and reduced hospitalization times.

The project will also act as stepping stone towards implantable biosensors, paving the way for future healthcare solutions

Upon successful completion, the project will empower and ease strain on healthcare systems and meet the needs of an aging population by producing innovative biomonitoring devices and software solutions. It aims to deliver advancements in technology, reduce healthcare costs, foster regional innovation, and create high-value job opportunities. The project will also act as a stepping stone towards implantable biosensors, paving the way for future healthcare solutions.

‍